Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.7 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.051 | 0.7 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |